Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Regression-based deep-learning predicts breast cancer recurrence risk score from pathology slides
    Meeting Abstract

    El Nahhas, O. S. M.; Loeffler, C. M. L.; Marra, A.; Carrero, Z.; Pareja, F.; Wen, H.; Weigelt, B.; Selenica, P.; Chandarlapaty, S.; Reis-Filho, J. S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan (T-DXd) versus treatment of physician's choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Updated survival results of the randomized, phase III DESTINY-Breast04 study
    Meeting Abstract

    Modi, S.; Jacot, W.; Iwata, H.; Park, Y. H.; Losada, M. J. V.; Li, W.; Tsurutani, J.; Zaman, K.; Ueno, N. T.; Prat, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • A pooled analysis of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) with brain metastases (BMs) from DESTINY-Breast (DB)-01,-02, and-03
    Meeting Abstract

    Hurvitz, S. A.; Modi, S.; Li, W.; Park, Y. H.; Chung, W.; Kim, S. B.; Cortés, J.; Yamashita, T.; Pedrini, J.; Im, S. A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Symptomatic necrosis with antibody-drug conjugates and concurrent stereotactic radiotherapy for brain metastases
    Research Letter

    Lebow, E. S.; Pike, L. R. G.; Seidman, A. D.; Moss, N.; Beal, K.; Yu, Y.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • T cell receptor therapeutics: Immunological targeting of the intracellular cancer proteome
    Review

    Klebanoff, C. A.; Chandran, S. S.; Baker, B. M.; Quezada, S. A.; Ribas, A.
    Nature Reviews Drug Discovery (2023)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial
    Journal Article

    Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Clinical decision support for chemotherapy-induced neutropenia using a hybrid pharmacodynamic/machine learning model
    Journal Article

    Hughes, J. H.; Tong, D. M. H.; Burns, V.; Daly, B.; Razavi, P.; Boelens, J. J.; Goswami, S.; Keizer, R. J.
    CPT: Pharmacometrics and Systems Pharmacology (2023)

    Fulltext@MSK | Save
  • Molecularly targeted therapies for triple negative breast cancer: History, advances, and future directions
    Review

    Mai, N.; Abuhadra, N.; Jhaveri, K.
    Clinical Breast Cancer (2023)

    Fulltext@MSK | Save
  • Incidence, risk factors, and management of alpelisib-associated hyperglycemia in metastatic breast cancer
    Journal Article

    Shen, S.; Chen, Y.; Carpio, A.; Chang, C.; Iyengar, N. M.
    Cancer (2023)

    Fulltext@MSK | Save
  • Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer
    Journal Article

    Jhaveri, K.; O’Shaughnessy, J.; Fasching, P. A.; Tolaney, S. M.; Yardley, D. A.; Sharma, V. K.; Biswas, C.; Thuerigen, A.; Pathak, P.; Rugo, H. S.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save